A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo.

Giannakopoulou, Eirini; Lehander, Madeleine; Virding Culleton, Stina; Yang, Weiwen; Li, Yingqian; Karpanen, Terhi; Yoshizato, Tetsuichi; Rustad, Even H; Nielsen, Morten Milek; Bollineni, Ravi Chand; Tran, Trung T; Delic-Sarac, Marina; Gjerdingen, Thea Johanne; Douvlataniotis, Karolos; Laos, Maarja; Ali, Muhammad; Hillen, Amy; Mazzi, Stefania; Chin, Desmond Wai Loon; Mehta, Adi; Holm, Jeppe Sejerø; Bentzen, Amalie Kai; Bill, Marie; Griffioen, Marieke; Gedde-Dahl, Tobias; Lehmann, Sören; Jacobsen, Sten Eirik W; Woll, Petter S; Olweus, Johanna

Giannakopoulou, Eirini; Lehander, Madeleine; Virding Culleton, Stina; Yang, Weiwen; Li, Yingqian; Karpanen, Terhi; Yoshizato, Tetsuichi; Rustad, Even H; Nielsen, Morten Milek; Bollineni, Ravi Chand; Tran, Trung T; Delic-Sarac, Marina; Gjerdingen, Thea Johanne; Douvlataniotis, Karolos; Laos, Maarja; Ali, Muhammad; Hillen, Amy; Mazzi, Stefania; Chin, Desmond Wai Loon; Mehta, Adi; Holm, Jeppe Sejerø; Bentzen, Amalie Kai; Bill, Marie; Griffioen, Marieke; Gedde-Dahl, Tobias; Lehmann, Sören; Jacobsen, Sten Eirik W; Woll, Petter S; Olweus, Johanna.

Affiliation

Giannakopoulou E; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Lehander M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Virding Culleton S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Yang W; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Li Y; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Karpanen T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Yoshizato T; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Rustad EH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nielsen MM; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Bollineni RC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tran TT; Genomics Group, Faculty of Biosciences and Aquaculture, Nord University, Bodø, Norway.
Delic-Sarac M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Gjerdingen TJ; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Douvlataniotis K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Laos M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Ali M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Hillen A; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Mazzi S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Chin DWL; Department of Immunology, Oslo University Hospital, Oslo, Norway.
Mehta A; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Holm JS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Bentzen AK; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Bill M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Griffioen M; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Gedde-Dahl T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lehmann S; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Jacobsen SEW; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Woll PS; Department of Cancer Immunology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Olweus J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Nat Cancer ; 4(10): 1474-1490, 2023 Oct.

Article de En | MEDLINE | ID: mdl-37783807

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein-tyrosine kinases / Leucémie aigüe myéloïde Type d'étude: Prognostic_studies Limites: Adult / Animals / Humans Langue: En Journal: Nat Cancer Année: 2023 Type de document: Article Pays d'affiliation: Norvège

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google